Abstract Oral Presentation

Moderator(s)

• 

  Maria Papaleontiou, MD

  Assistant Professor
  University of Michigan
  Ann Arbor, Michigan, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentations:

• 1:30 PM – 1:50 PM

  Osilodrostat Therapy Improves Physical Features Associated with Hypercortisolism in Patients with Cushing’s Disease: Findings from the Phase III LINC 3 Study
  

  Submitter: Alberto M. Pedroncelli, MD, PhD – Recordati AG
• 1:50 PM – 2:10 PM

  Effect of Resmetirom, a Selective Thyroid Hormone Receptor Beta Agonist, On Hepatic Hypothyroidism in a 52-Week Non-Cirrhotic NASH Phase 3 Clinical Trial
  

  Submitter: Kathryn Jean Lucas, MD – Lucas Research, Inc.
• 2:10 PM – 2:30 PM

  Thyroid Fine Needle Aspirates Containing Both BRAF V600E and TERT Promoter Mutations Show Unique Differential microRNA Expression Patterns
  

  Submitter: Sydney D. Finkelstein, MD – Interpace Diagnostics